Webinars6.29.22
IP Considerations for Emerging Companies: Perspectives From Europe and the U.S.

Life sciences companies begin their life cycle with ideas, and emerge due to synergistic core assets surrounding those ideas: intellectual property for protection and dedicated people for development.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
